CLINICAL INFORMATION

Read on for more information about Prekulab and its clinical trials, plus further news and research on Phe and phenylketonuria.

CLINICAL INFORMATION

Read on for more information about Prekulab and its clinical trials, plus further news and research on Phe and phenylketonuria.

About us

Prekulab's mission is to improve the life quality of people with PKU.

With a wealth of experience stretching back to 1970, the firm is a specialist in the field of PKU research and products. It uses its substantial knowledge about the area to develop new solutions to help families and those affected by PKU to lead as normal a life as possible. Prekulab is a pioneer in the use of LNAA to allow a more liberal diet for patients.

Prekulab established a successful long-term collaboration with the J.F. Kennedy Institute in Denmark (now Rigshospitalet, Copenhagen) at the leading edge of the treatment of PKU-related diseases, and works globally with specialist clinics and universities including the Los Angeles Children’s Hospital, the Department of Pediatrics at the University of Milan and the Clinical Centre of Genetics in Moscow.

Specialised medical foods

For decades, Prekulab has developed and supplied specialised medical foods that allow PKU patients to live better and more ordinary lives. Its first product, Avonil, offers an odour and taste-free PKU option, and along with its second product, PreKUnil, has been helping patients manage PKU for over 30 years.

In 2004, Prekulab developed NeoPhe, a breakthrough in modern PKU treatment, which uses an improved LNAA dietary supplement to allow patients to follow a more liberal diet. Prekulab formulations are protected by patents in the EU, US and China and are clinically proven. Products are manufactured in Denmark with strict GMP compliance.

Prekulab is headquartered in Denmark, and has a global network of agents and distributors. In 2018 it opened its first international subsidiary, Prekulab Turkey. Prekulab’s staff are focused on expanding its distribution network to bring its products to a wider range of patients, worldwide. The team attends all relevant PKU-focused conferences around the world, offering a personal presence for clinicians and patients and encouraging global collaboration.

Patient studies and research

Prekulab works with experts and clinicians around the world to conduct patient studies and participate in research programmes. It is the only provider of such products that can document its results through clinical trials. Prekulab is keen to contribute to new studies and further drug development programmes.

Prekulab continues to be committed to making the lives of those with PKU and their families easier

CLINICAL INFORMATION

Read on for more information about Prekulab and its clinical trials, plus further news and research on Phe and phenylketonuria.

About us

Prekulab's mission is to improve the life quality of people with PKU.

With a wealth of experience stretching back to 1970, the firm is a specialist in the field of PKU research and products. It uses its substantial knowledge about the area to develop new solutions to help families and those affected by PKU to lead as normal a life as possible. Prekulab is a pioneer in the use of LNAA to allow a more liberal diet for patients.

Prekulab established a successful long-term collaboration with the J.F. Kennedy Institute in Denmark (now Rigshospitalet, Copenhagen) at the leading edge of the treatment of PKU-related diseases, and works globally with specialist clinics and universities including the Los Angeles Children’s Hospital, the Department of Pediatrics at the University of Milan and the Clinical Centre of Genetics in Moscow.

Specialised medical foods

For decades, Prekulab has developed and supplied specialised medical foods that allow PKU patients to live better and more ordinary lives. Its first product, Avonil, offers an odour and taste-free PKU option, and along with its second product, PreKUnil, has been helping patients manage PKU for over 30 years.

In 2004, Prekulab developed NeoPhe, a breakthrough in modern PKU treatment, which uses an improved LNAA dietary supplement to allow patients to follow a more liberal diet. Prekulab formulations are protected by patents in the EU, US and China and are clinically proven. Products are manufactured in Denmark with strict GMP compliance.

Prekulab is headquartered in Denmark, and has a global network of agents and distributors. In 2018 it opened its first international subsidiary, Prekulab Turkey. Prekulab’s staff are focused on expanding its distribution network to bring its products to a wider range of patients, worldwide. The team attends all relevant PKU-focused conferences around the world, offering a personal presence for clinicians and patients and encouraging global collaboration.

Patient studies and research

Prekulab works with experts and clinicians around the world to conduct patient studies and participate in research programmes. It is the only provider of such products that can document its results through clinical trials. Prekulab is keen to contribute to new studies and further drug development programmes.

Prekulab continues to be committed to making the lives of those with PKU and their families easier

About us

Prekulab's mission is to improve the life quality of people with PKU.

With a wealth of experience stretching back to 1970, the firm is a specialist in the field of PKU research and products. It uses its substantial knowledge about the area to develop new solutions to help families and those affected by PKU to lead as normal a life as possible. Prekulab is a pioneer in the use of LNAA to allow a more liberal diet for patients.

Prekulab established a successful long-term collaboration with the J.F. Kennedy Institute in Denmark (now Rigshospitalet, Copenhagen) at the leading edge of the treatment of PKU-related diseases, and works globally with specialist clinics and universities including the Los Angeles Children’s Hospital, the Department of Pediatrics at the University of Milan and the Clinical Centre of Genetics in Moscow.

Specialised medical foods

For decades, Prekulab has developed and supplied specialised medical foods that allow PKU patients to live better and more ordinary lives. Its first product, Avonil, offers an odour and taste-free PKU option, and along with its second product, PreKUnil, has been helping patients manage PKU for over 30 years.

In 2004, Prekulab developed NeoPhe, a breakthrough in modern PKU treatment, which uses an improved LNAA dietary supplement to allow patients to follow a more liberal diet. Prekulab formulations are protected by patents in the EU, US and China and are clinically proven. Products are manufactured in Denmark with strict GMP compliance.

Prekulab is headquartered in Denmark, and has a global network of agents and distributors. In 2018 it opened its first international subsidiary, Prekulab Turkey. Prekulab’s staff are focused on expanding its distribution network to bring its products to a wider range of patients, worldwide. The team attends all relevant PKU-focused conferences around the world, offering a personal presence for clinicians and patients and encouraging global collaboration.

Patient studies and research

Prekulab works with experts and clinicians around the world to conduct patient studies and participate in research programmes. It is the only provider of such products that can document its results through clinical trials. Prekulab is keen to contribute to new studies and further drug development programmes.

Prekulab continues to be committed to making the lives of those with PKU and their families easier

NeoPhe Tablets and Powder

Our newest and most advanced LNAA product gives double protection from Phe, stopping it from entering the brain and also inhibiting entry to the blood. Clinically proven NeoPhe is available in odour and flavourless tablets and citrus-flavoured powder, and allows PKU patients to get up to 80% of their protein intake from a normal diet.

NeoPhe tablets    NeoPhe powder   

NeoPhe Tablets and Powder

Our newest and most advanced LNAA product gives double protection from Phe, stopping it from entering the brain and also inhibiting entry to the blood. Clinically proven NeoPhe is available in odour and flavourless tablets and citrus-flavoured powder, and allows PKU patients to get up to 80% of their protein intake from a normal diet.

NeoPhe tablets    NeoPhe powder   

PreKUnil Tablets

This advanced product pioneered the use of LNAAs in the treatment of phenylketonuria. It has been successful for PKU patients for more than 30 years. It is clinically proven to reduce Phe transport across the blood-brain barrier. PreKUnil allows PKU patients to get up to 80% of their protein intake from a normal diet. It is also suitable for late-diagnosed and untreated PKU.

PreKUnil tablets

PreKUnil Tablets

This advanced product pioneered the use of LNAAs in the treatment of phenylketonuria. It has been successful for PKU patients for more than 30 years. It is clinically proven to reduce Phe transport across the blood-brain barrier. PreKUnil allows PKU patients to get up to 80% of their protein intake from a normal diet. It is also suitable for late-diagnosed and untreated PKU.

PreKUnil tablets

Avonil Tablets and Powder

A conventional method for the management of PKU, Avonil contains all essential amino acids except Phe, plus multiple vitamins and minerals. Tablets are formulated for easy swallowing, while the powder is mixed with water or juice to drink. Tablets and powder are suitable for all ages, including children and during pregnancy, and must be combined with a restricted diet.

Avonil tablets    Avonil powder   

Avonil Tablets and Powder

A conventional method for the management of PKU, Avonil contains all essential amino acids except Phe, plus multiple vitamins and minerals. Tablets are formulated for easy swallowing, while the powder is mixed with water or juice to drink. Tablets and powder are suitable for all ages, including children and during pregnancy, and must be combined with a restricted diet.

Avonil tablets    Avonil powder   

General

Large neutral amino acids in the treatment of PKU: from theory to practice (2010)
PDF, 142 Kb, English

Large neutral amino acids supplementation in phenylketonuric patients (2009)
PDF, 213 Kb, English

Large neutral amino acids in daily practice (2009)
PDF, 99 Kb, English

Large neutral amino acids in the treatment of phenylketonuria (PKU) (2006)
PDF, 292 Kb, English

Large neutral amino acid therapy and phenylketonuria: a promising approach to treatment (2003)
PDF, 145 Kb, English

Effect on blood phenylalanine

Double blind placebo control trial of large neutral amino acids in treatment of PKU: Effect on blood phenylalanine (2007)
PDF, 278 Kb, English

Effect on brain phenylalanine

Brain phenylalanine concentrations in phenylketonuria: Research and Treatment of Adults (2003)
PDF, 132 Kb, English

Future role of large neutral amino acids in transport of phenylalanine into the brain
PDF, 142 Kb, English

Late diagnosed, untreated and non-compliant PKU

A diet with large neutral amino acids supplementation as a combined treatment for difficult to control or late diagnosed patients with PKU
PDF, 108 Kb, English

Amino acid tablets in untreated PKU
PDF, 57 Kb, English

Large neutral amino acid supplementation improves executive functions in diet non- compliant phenylketonuria adolescents
PDF, 408 Kb, English

Contact a PKU expert

Ask our team about how Prekulab products
can help you or your child’s PKU.



  Contact us  

Contact a PKU expert

Ask our team about how Prekulab products can help you or your child’s PKU.



  Contact us  

Contact a PKU expert

Ask our team about how Prekulab products
can help you or your child’s PKU.



  Contact us  

Contact a PKU expert

Ask our team about how Prekulab products can help you or your child’s PKU.



  Contact us